胰岛素受体异型和胰岛素生长因子类受体:对细胞信号,致癌和化学抵抗的影响
Mariam Ahmed Galal1,2, Samhar Samer Alouch1, Buthainah Saad Alsultan1
1Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
胰岛素受体 (IR) 和胰岛素样生长因子受体 (IGFR) 信号驱动癌症的发展和化学抵抗. 针对IR和IGFR,可以克服治疗耐药性,从而改善癌症治疗.
科学领域:
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
- 癌症研究 癌症研究
背景情况:
- 胰岛素和胰岛素类生长因子信号传递 (IIS) 途径涉及连接体,受体和结合蛋白.
- 这一途径调节关键的细胞功能,包括致癌和化学抵抗.
- 胰岛素受体 (IR) 和胰岛素样生长因子受体 (IGFR) 信号传递是IIS通路的关键组成部分.
研究的目的:
- 综合审查IR和IGFR异型在癌症中的作用.
- 探索它们在致癌和化学抵抗中的参与.
- 确定针对这些受体的潜在治疗策略.
主要方法:
- 对IR和IGFR结构和异型的遗传分析.
- 关于IR和IGFR在癌症中的过度表达的文献综述.
- 信号通路相互作用和药物耐药性机制的分析.
主要成果:
- 显著的IR和IGFR异型产生的替代拼接与各种联结体亲和力.
- 过度表达IR-A与癌症干,瘤发育和治疗耐药性有关.
- 提高IGFR表达促进瘤进展和化学抵抗,IR-IGFR相互作用有助于抗IGFR药物耐药性.
结论:
- 红色激素和IGFR在细胞信号传递,致癌和治疗耐药性方面发挥着关键作用.
- 双重向IR和IGFR可能提供一种更有效的抗化学抵抗策略.
- 调节这些受体有潜力开发增强的抗癌干预措施.
更多相关视频
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
相关概念视频
Insulin: The Receptor and Signaling Pathways
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Signal Transduction: Overview
Typically, signal transduction involves three...
